| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.008 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |